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We report upon a novel coplanar dielectrophoresis (DEP) based cell patterning system for generating
transferrable hepatic cell constructs, resembling a liver-lobule, in culture. The use of paper reinforced gel
substrates provided suﬃcient strength to enable these constructs to be transfered into 96-well plates for
long term functional studies, including in the future, drug development studies. Experimental results
showed that hepatic cells formed DEP ﬁeld-induced structures corresponding to an array of lobule-
mimetic patterns. Hepatic viability was observed over a period of 3 days by the use of a ﬂuorescent cell
staining technique, whilst the liver speciﬁc functionality of albumin secretion showed a signiﬁcant
enhancement due to the layer patterning of cell lines (HepG2/C3A), compared to 2D patterned cells and
un-patterned control. This “build and transfer” concept could, in future, also be adapted for the layer-by-
layer construction of organs-on-chip in microtitre formats.Introduction
Cellular patterning is an enabling technology and can be used
to build cell-based architectures from the bottom up. The
technique has been widely used in a variety of applications
associated with organ replacement,1 medical diagnostics2 and
drug delivery.3 Such studies have demonstrated that the repli-
cation of both in vivo geometries and dimensional scale
contributes to the recapitulation of in vivo-like cell phenotypic
architectures within in vitro constructs.4 Engineered micro-
structures and patterns based upon a specic organ have also
been shown to strongly enhance the functionality of co-cultures
of diﬀerent cell-types, aimed at recapitulating the activity of the
organ.4–6
Organs-on-chip or tissue-on-chip are microengineered plat-
forms that integrate physiologically relevant local environments
within cultured biological tissues.7–9 A growing number of
diﬀerent anatomical structures have been established,
including the spleen,10 lungs,11 interconnected neurons12 and
intestinal villi.13 Their use is supported by a wide range of
modelling and control systems such as whole-bodyals Science (ACES), Australian Centre for
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hemistry 2018pharmacokinetic pharmacodynamics (PK–PD) modelling14 to
study drug activities for example. Engineered micro-organs
have also shown promise to both improve the accuracy and
reduce development costs of drug compounds.15 The liver is an
essential organ when considering toxicity studies in the process
of drug development and the reconstruction of functional tissue
assemblies has the potential to provide highly relevant surro-
gate models.16,17
Patterning biomimetic liver-on-a-chip has been achieved
using a variety of microengineering and microfabrication
technologies.18–23 Successfully generating the building block of
the liver (lobules – consisting of a unit of hepatocytes lined by
endothelial cells – hepatic cords) has been an important
development.24,25 A number of devices have used trapping
systems to reform various cell types into hepatic cords, as
demonstrated by using microuidic channels lined with micro
pillars fabricated to culture hepatocytes into hepatic cords.21
Such micro-engineered devices have also been used to test drug
toxicity in vitro,22 and co-culture A549 and C3A cells.26
Endothelial-like microuidic barriers can also be fabricated to
align into a hepatocyte arrangement.18,20 The complexity of
these devices has resulted in research into microuidic on-chip
construction of lobule like structures.19 Hepatocytes and non-
parenchymal cells have also been accurately arranged into
hepatic sinusoids by fabricating cell-laden hydrogel
microbers.23
Dielectrophoresis (DEP)27,28 has also previously been used to
successfully engineer liver lobule patterns on-chip with both
human liver cell line (HepG2)29 and human umbilical vein
endothelial cells (HUVECs).30 The 3D patterning of rat hepato-
cytes in various biomimetic microstructures within a photo-
polymerisable polyethylene glycol (PEG) hydrogel has also beenRSC Adv., 2018, 8, 9603–9610 | 9603
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View Article Onlinedemonstrated.31 These successful DEP patterning systems
however are limited by their reliance upon specic device
designs, which can only be used once (one culture, one device).
Further, they do not provide a re-useable platform for
patterning cells within a 3D hydrogel, and perhaps most
importantly, the resulting geometries are not appropriate for
high throughput methods, commonly used within drug
screening laboratories.
Within cell-tissue patterns, full biological activity only
appears in a coherent and functional fashion aer being
cultured for several days. Many microdevice formats currently
proposed oen do not allow such longer-term incubation, for
example due to the fragility of the hydrogel layer or as a conse-
quence of the need for an iterative disassembly/re-assembly.31–33
To date this has prevented a seamless transfer of the tissue
structures to higher throughput conventional culture dishes,
thereby restricting the use of DEP-patterned hydrogels in
applications where a high number of experiments are required
such as in drug development applications.
Here we show that the use of support structures, conve-
niently manufactured in paper matrices, enables the assembly
of the cell-tissue constructs within a microdevice, (using DEP in
an open-top co-planar electrode conguration) which can then
be followed readily by its extraction and its positioning into a 96
well plate for subsequent culture and analysis (Fig. 1).
Previously, hydrogels and agar have both been shown to be
useful for tissue engineering, providing a suitable microenvi-
ronment for mammalian cells.33 For example, agar scaﬀolds
have been developed which enable HepG2 liver cell culture34
providing both biocompatibility and porosity and allowing the
ready diﬀusion of nutrients and gases to cells at temperatures
above 30 C. Recently, thin hydrogel lms have been used to
provide an alternative to conventional extracellular matrix
(ECM) for culture with a range of cell types under perfusion.35
In this paper, we now build upon this previous work, and use
DEP patterning in hydrogels for the creation of a liver-like
biomimetic architecture. The technique has a number of
advantages in that the devices are scalable into higher
throughput formats and have a co-planer design such that they
are 96-well plate compatible. The system also maintains a cell
pattern in the hydrogel, with the potential to stack multiple
layers with diﬀerent patterns, cell types and hydrogels. To create
complex 3D architectures in future, the cell-laden gel layers
could be partially melted to increase cell–cell contacts. The
equipment also has the advantage that it is reusable.
We now show that liver specic functions were enhanced in
this new conguration (illustrated here with the secretion of
albumin). The system uses an innovative method, integrating
temperature control with Peltier coolers, laser cut paper rings
and patterning of cell within a hydrogel, to produce a reusable
cell patterning system (“build”) that can enable the assembly of
layers of biomimetic cell-laden hydrogels either with micro-
uidic or static culture conditions.
Further, we demonstrate that cell viability was maintained
over a period of three days, when cells were patterned within
the hydrogel. The C3A liver cells exhibited a more liver-like9604 | RSC Adv., 2018, 8, 9603–9610functional behaviour, as illustrated by their increased secre-
tion of albumin, with respect to non-patterned cells.Materials and methods
Materials
Cell lines HepG2/C3A were acquired from ATCC, UK. All chem-
icals were supplied by Sigma-Aldrich, UK unless otherwise stated.
Eagle's Minimum Essential Medium (EMEM) was supplied by
ATCC, UK and EMEM was supplemented with 10% fetal bovine
serum. Trypsin 0.25%, dimethyl sulfoxide (DMSO) and phos-
phate buﬀered saline (PBS) were of a grade compatible with cell
culture. DEP buﬀer comprised 9% sucrose, 0.3% dextrose, 3 mM
HEPES in DI water; conductivity 13 mS m1 pH 7.4, osmolality
300 mOsm. Albumin Human ELISA kit (ab108788) was obtained
from Abcam, Cambridge, UK. Trypan Blue solution, 0.25% and
LIVE/DEAD® Viability/Cytotoxicity Kit, for mammalian cells were
obtained from Life Technologies, UK.
Low gelling temperature agarose (Type IX-A: Ultra-low
Gelling Temperature) for cell culture was obtained from
Sigma-Aldrich. Petri dishes, 6, 24 and 96-well plates, sterile
single use pipettes, Eppendorf tubes, and microscope slides
were obtained through Fisher Scientic, UK. Whatman no. 114
(USA) lter paper was obtained through Sigma-Aldrich. Nes-
colm was obtained from Alfresa Pharmaceutical Corp, Osaka,
Japan. To perform DEP, a 50 MHz TG5011 LX1 frequency
generator (Thurlby Thandar Instruments Ltd, UK) was used.
Temperature control was maintained using a pair of Peltier
coolers (MULTICOMP – MCPE-071-10-13, 19.1 W, 1639748)
supplied by Farnell, controlled by a dual-rail current supply EX
354D 280 W (Thurlby Thandar Instruments Ltd, UK).
A Hewlett–Packard (HP) DesignJet was used to fabricate the
cover for the system. Parts were le in a water bath at 60 C
with a mixture of sodium percarbonate, carbonate and bicar-
bonate with de-ionised (DI) water. Passive cooling solutions
were provided by a selection of heatsinks: heatsink 6.8 C W1
(36-0292) from Rapid Electronics, UK and Zalman CNPS7000a-
CU from Zalman, USA. Thermal connection was made by
a proprietary paste (36-0400) from Rapid Electronics, UK.
Standard mechanical grade silicon thickness 500 mm, 4 inch
wafers were supplied by University Wafer, USA. Additionally,
gold (Au) and titanium (Ti) wire for resistive heating evapo-
ration deposition were supplied by the James Watt Nano-
fabrication Centre and were obtained from Goodfellows UK.Cell culture and analysis
Cell lines were cultured in a HERA cell 150 incubator (Thermo
Scientic) and maintained at 37 C with 5% CO2. Antibiotics
were used prophylactically in cell culture maintenance
however, it has been observed that they cause disruption of
cellular functions including cell morphology, cellular degen-
eration and cell death.36 For example, hepatocytes have been
observed to have reduced metabolic function when cultured
with penicillin, a commonly used antibiotic in cell culture.37 As
toxicity studies using hepatic cell lines are reliant on repro-
ducible data from protein synthesis, antibiotics were not usedThis journal is © The Royal Society of Chemistry 2018
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View Article Onlinein this work. The live/dead kit viability kit was used according
to the supplier instructions to assess the health of the C3A
cells by simultaneously staining the living and dead cells.
Albumin secretion analysis
The cell culture medium was collected from the wells and
stored in 1.5 ml Eppendorf tubes at 4 C. The albumin
concentration was measured using the human albumin assay
kit following the supplied protocol (ab108788, Abcam, Cam-
bridge, UK). Assays were performed in duplicate for each
sample. Medium samples including 2D control, agar control,
and pattern samples were collected each day and stored at
20 C until assayed. The data from the plate-reader was
averaged across 4 separate experiments. Analysis of variance
(ANOVA) was performed using GraphPad Prism v7.03
(GraphPad Soware, Inc., U.S.A.).
Characterisation
Measurements for albumin production were taken with a Bio-
Tek ELx808 high throughput plate reader at 450 nm and 520 nm
accordingly. Data was acquired using the supplied soware
package Gen5™. Fluorescence microscopy was carried out on
a Zeiss D.1 Axio Observer. A mercury lamp (HBO 100) was used
to excite uorophores, and ltered using uorescein iso-
thiocyanate (FITC) (XF100-2) and rhodamine (Rho) (XF101-2)
lters; excitation at 475 and 525 nm, emission at 535 and 565
respectively. The microscope objectives used were: Zeiss EC
Plan-NEOFLUAR 5, 10 and 20. Images were captured
using an Andor tech iXOn EM+ camera with a 60N-L 1.0 collar.
Images were collected and processed using the ImageJ soware
package.38
Osmolarity of solutions was measured using an Advanced
Micro Osmometer 3300, calibrated using standards of 850, 290
and 50 mOsm kg1 supplied by Advanced Instruments, UK.
Conductivity was measured using a Jenway 4071 conductivity
meter (288-8199) obtained from RS, UK. pHmeasurements were
taken using a Hanna Instruments pH meter and calibratedFig. 1 Illustration of the “build and transfer” system. (a) Utilising a single
where patterned within an agar hydro-gel supported by a 6.2 mmOD, 5 m
the liquid state of the agar, then cooled to cure the agar into a gel. Pattern
Supported by a paper-ring substrate, the patterned cells were removed
well plate for incubation and subsequent biological analysis. Scale bar is
This journal is © The Royal Society of Chemistry 2018using standards of 4.0, 7.0 and 10.0 pH (Fisher). Thermal
imaging was performed using a Ti 25 Fluke thermal camera
from Fluke, Norwich, UK. Direct thermal readings were taken
from devices using a thermocouple CM1200T (IEC 584-3)T from
Caltek Industrial (H.K.) Ltd, Hong Kong.Electrode fabrication
DEP electrodes, in patterns that mimicked the liver lobule, were
fabricated using photolithography and metallisation to dene
electrodes of Pt (10 nm)/Au (100 nm) suitable for DEP,
connectors were then soldered to the electrodes. The fabrica-
tion process used for the electrodes in this work follow the well-
dened photolithographic techniques.393D design
2D and 3D CAD drawing was completed in SolidWorks 2011
64 (Dassault System SolidWorks Corp, Concord, MA, USA),
completed .stl les were veried using Solid Edge (Siemens
PLM Soware, UK). Completed .stl les were then processed by
HP Designjet 3D Soware Solution for the HP DesignJet,
ProJet®.Hydrogel and paper substrate preparation
C3A cells were harvested from 70% conuent cultures and
detached from the surface of 25 ml culture asks using 0.25%
trypsin–EDTA. The cell solutions were diluted with 5 ml of
warmed (37 C) EMEM and then pipetted into a 15 ml centri-
fugation tube. Cells were centrifuged for 3 minutes at 1500 rpm
(312  g) to form a so cell pellet. Waste media was gently
removed from the tube using pipetting, the nal solution being
removed using a 200 ml pipette in order to reduce transfer of
extra ions into the nal solution. The pellet was then pipetted
with 5 ml of DEP buﬀer. A low conductivity was selected to
maximise the dielectrophoretic forces exerted on the cells.40 The
suspended cells were then centrifuged again at the same
settings; the process was repeated 3 times. Finally, 200 ml of DEPplane biomimetic DEP electrode arrangement, C3A human liver cells
m ID paper ring. The system was heated during patterning to maintain
ingwas induced by positive DEP through a 10MHz, 10 Vpp AC signal. (b)
by tweezers. (c) Patterned cells were then immediately placed in a 96-
5 mm.
RSC Adv., 2018, 8, 9603–9610 | 9605
Fig. 2 The “build and transfer” system setup and operation for
patterning liver like structures within an agar gel with a paper substrate.
(a) Warmed 1% agar solution with randomly distributed cells at 37 C
was pipetted into volume designated by the gasket. The Peltier
warmed the glass substrate on which the electrodes are situated and
enclosed with a cover. (b) Hepatic cells were captured by positive DEP
forces (F_DEP) induced by a non-uniform electric ﬁeld (10 MHz, 10
Vpp). (c) Once patterning was complete, the Peltier was switched to
cooling mode dropping the temperature of the agar to 18 C, curing
the gel. Once the air temperature reached 25 C the AC ﬁeld was
switched oﬀ. Agar 1% solution enters gel phase at this temperature. (d)
The cells patterned by the DEP forces are held in place by the cured
agar. The paper substrate containing a biomimetic micro liver is used
to manipulate the patterned cells into a culture system.
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View Article Onlinebuﬀer was added to the cell pellet to yield a cell concentration of
2.5  106 cell/200 ml. This concentration was selected to provide
125  105 cells/10 ml, which was the designed volume used to
fabricate the micro liver.
Low-gelling agar was dissolved by boiling with DEP buﬀer to
give a nal agar concentration of 2% (w/v). Batches of this buﬀer
were sterilised by autoclave to ensure sterile conditions for the
cells. This agar solution was maintained at 37 C in a water bath
until required. A pre-warmed (37 C) Eppendorf 1.5 ml tube was
used to mix 1 : 1, agar 2% solution with 2.5  106 cell per ml
concentrate DEP buﬀer; yielding a 1% agar solution of 1.25 
106 cell per ml with DEP buﬀer (a concentration corresponding
to ca. two liver lobules).41 This nal solution was kept at 37 C
before use in DEP-based cell-patterning experiments.
Agar and paper substrate manipulation
As shown in Fig. 1(a) the top of the electrodes had a 100 mm
gasket made from Nescolm with a 5 mm diameter hole cut in
the centre. This dened the volume of the agar cell solution to
be patterned. Around the circumference of this gasket a 5 mm
ID, 6.2 mm OD paper ring previously soaked in 2% (w/v) agar
was placed. This dened a 7.7 pl volume for electrode
patterning. The paper construct was incubated to stop the
wicking of 1% agar DEP buﬀer cell solution into the cellulose
matrix. A 10 ml agar cell solution was pipetted into this volume
for patterning. Finally, patterned gels were removed from the
container with the support of the paper ring using tweezers,
Fig. 1(b) and placed inside a 96-well as shown in Fig. 1(c) with
growth medium for subsequent cell culture.
System design and operation
The design and operation is illustrated in Fig. 2. Micro-
fabricated Pt/Au electrodes on the surface of a glass substrate
were used to build a micro liver in agar with a paper substrate.
The substrate was placed on a Peltier cooler. A 3D printed cover,
designed in SolidWorks and fabricated with the fused deposi-
tion modelling HP DesignJet, was employed to reduce evapo-
ration during the patterning process. A copper heat sink was the
base of the system, which was connected to the Peltier reversibly
with thermal paste. A drop of deionised (DI) water acted as
a thermal interface between the Peltier and the glass. In order to
keep the 1% agar-cell solution in a liquid state (viscosity typi-
cally 60 mPa s1)42 to allow for cell movement into the desired
patterns, the temperature was maintained at 37 C.
Following patterning, the system is then cooled to 18 C by
reversing the current of the Peltier and the AC eld is switched
oﬀ once the air temperature has dropped to 25 C, at which
point the agar gels,43 ‘freezing’ the pattern., which was then
manipulated through the paper ring and transferred to
conventional cell culture plates for long term studies.
Results and discussion
Electrode design
The human liver consists of two lobes, which are irregular in
shape and divided by the falciform ligament Fig. 3(a). In9606 | RSC Adv., 2018, 8, 9603–9610mammals, the hierarchical structure of these lobes nally end
in 105 to 106 functional units called lobules.44 In cross-section,
the hepatocytes are seen to be arranged in plates of one to
two cells thick, organised radially around the central vein in
cords, as illustrated in Fig. 3(a), separated by sinusoids. Our
DEP system design is inspired from this anatomical data, as
illustrated in Fig. 3(b): the inner branches of the electrodes
(grey) were connected to an alternating current (AC) supply, the
outer connection (black) to the ground line. The design uses 19
lobules, giving the array dimensions of 5  4.6 mm. This array
size was chosen to allow it to t easily within industry standard
96-well plates (6.86/6.35 mm (top/bottom) in diameter). The 10
mm electrode width replicates the sinusoids in the liver.45 The
central point of each lobule was designed to be 80 mm in
diameter corresponding to the diameter of the centrilobular
vein, and similarly for the width (1 mm) and sides (500 mm) of
the lobule, also with relation to anatomical data.46
Before cell patterning experiments for C3A cells (10–15 mm in
diameter), we established the most sensitive signal frequency to
use for DEP manipulation. Cells mixed with DEP buﬀer and
agar to make a 1% (w/v) solution were pipetted onto the elec-
trodes. We observed electric-eld induced negative DEP, where
cells are repelled away from the electrodes, at frequencies close
to 10 kHz, while strong positive DEP, where the cells were
attracted to the areas of high eld gradients, towards the elec-
trodes, was generated at elds over 1 MHz. A voltage amplitudeThis journal is © The Royal Society of Chemistry 2018
Fig. 4 Viability of patterned lobule like structures. (a) Viability of 2D
control (black), agar control (light grey), and C3A lobule like structures
(dark grey) for a period of 72 h. Cell viability in the control was
consistently higher than the agar control or pattern by 72 h (87.64 
2.0%). Comparatively, the agar control was observed to be 73.6 
11.3% and the pattern was 71.3 5.6%. Data represent the mean STD
for four independent repeats. Statistically there was no signiﬁcant
diﬀerences between the 3 sample groups. p > 0.05 (ANOVA). (b)
Microscope images of C3A cells after 72 hours of culture. (1–3) 2D
sample spread across the surface of the well-plate. (4–6) C3A cells
encapsulated within agar gel; cells in close proximity formed small
aggregates or spheroids. (7–9) Patterned cells maintained position
while forming cords of cells in the shape of the original design. Scale
bars 100 mm.
Fig. 3 Electrode design. (a) The liver is the largest organ in the body
and receives blood from the hepatic portal vein and the hepatic artery.
The liver is composed of small units, which can be described in
a number of ways. One of the common descriptions is the “classic
lobule”.47 The lobules are approximately hexagonal in cross-section,
with the central vein (80 mm diameter) in the centre surrounded
radially by sinusoids constructed of hepatocytes. Microelectrode
design for inducing DEP forces to pattern cells into a micro liver lobule
array. (a) Using a biomimetic electrode design, hepatocytes are
patterned into an array 19 lobules in size using DEP forces. The largest
gap is 60 mmbetween the electrodes. The width of the electrodes is 10
mm, thickness 100 nm. (b) Microscope image showing C3A liver cells
being held in place by DEP forces to form liver lobule like structures (10
MHz, 10 Vpp for 2 min). Scale bar is 200 mm.
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View Article Onlineof 10 Vpp was chosen to increase positive DEP forces without
any loss of cell viability. These observations are in agreement
with previous studies of DEP based cell patterning.31,48
The patterned cells, inside the agar, structured on the paper
ring, were then cooled below the gelling temperature (25 C)
using the Peltier device and manually transferred to culture
plates Fig. 1(a). It is important to note that the cells were mixed
with the agar solution, eﬀectively encapsulated once it cured.
The patterning process only lasted a fewminutes preventing cell
sedimentation and attachment. When the paper substrate was
manipulated and transferred, all cells were transferred as well
together with the gel. Experiments using lower concentrations
of agar (0.8, 0.5 and 0.25%) resulted in the gel not attaching to
the paper ring.Cell viability assessment for DEP cell patterning in agar
The in vitro cell viability was assessed using the mammalian
live/dead assay kit, a uorescence-straining method which
stains in green the cytoplasm of live cells and in red the nucleusThis journal is © The Royal Society of Chemistry 2018of dead cells. Fig. 4 shows that the viability of C3A lobule-like
structures in agar increased over 72 h to 71.3  5.6% (%
green uorescent cells). Cells cultured in standard and 3D
conditions in well plates (cells seeded in agar on the DEP device
but without 2D patterning) had a viability of 87.64  2.0%.
Images in Fig. 4(b) are a composite of both live cells (green) and
dead cells (red) images. Viability data indicates that the DEP
patterning system had no signicant eﬀect on the cells. Cell
density was observed to double aer 48 h in 2D controls, faster
than for the cultures in gels (both patterned and unpatterned),RSC Adv., 2018, 8, 9603–9610 | 9607
Fig. 5 Albumin production of lobule like structures. (a) Albumin value
(ng mL1) of control (black), agar control (light grey), and patterned
C3A cells (dark grey) over 72 h. Patterned C3A cells had increased
albumin secretion after 48 h of culture compared to the control and
monolayer control. The control samples show a stable production
over the ﬁrst two days before decreasing. Data represent the mean 
STD for four independent repeats. The (*) indicates statistically
signiﬁcant increase in albumin protein of patterned cells relative to
control, and agar 48 h, p # 0.05 (ANOVA). (b) Viability images of
control, agar control, and patterned cells. Images are a composite of
both live cells (FITC-green) and dead cells (rhodamine – red) images.
Scale bars 100 mm.
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View Article Onlineand in close agreement with previous studies of 3D cell
cultures.31
Successful patterning with DEP, as observed in Fig. 4(b), led
to the development of cell morphologies that are relevant of
their functionalities, correlating to the original lobule pattern
and fusing with neighbouring cells. They produced dense,
cord-like chains of hepatocytes as shown in Fig. 4(b).
Aggregation of cells was observed in the 3D control,
however, due to the random distribution of cells through the
agar, only spheroid-like aggregates were observed shown in
Fig. 4(b), which is in agreement with the literature.49,50
Agglomeration of HepG2 has been conrmed to be benecial
for cell function and viability.51 While the factors that modu-
late the hepatocyte phenotype in vitro remain to be elucidated,
it is accepted that heterotypic cell interaction between hepa-
tocytes modulate cell growth, migration and/or
diﬀerentiation.52
Contrary to previously published 2D DEP strategies in
microuidic systems,32,53 our patterns can be maintained for
longer periods of time, providing a useful platform for a large
range of applications in drug development for example. As
shown in our 2D control results, 2D culture puts signicant
constraints on cell density and the duration of incubation, as
cells grow quickly, overcoming the patterns created within less
than 48 h.9608 | RSC Adv., 2018, 8, 9603–9610Micro liver function assessment via albumin secretion
To explore the potential of our method to perform bioassays, we
assessed albumin secretion over 3 days, using an ELISA shown
in Fig. 5. Albumin secretion is a liver-specic function for
hepatocytes, requiring liver-specic gene expression and intact
translational and secretory pathways in the cells.54 Patterned
C3A cells showed statistically-signicant increased albumin
secretion aer 48 h of culture (233  46 ng ml1) compared to
the agar control (184 54 ng mL1) andmonolayer control (167
 51 ngmL1). The control samples showed a stable production
over the rst two days before decreasing aer 72 h. However, the
concentration decreased for all conditions aer 72 h, while
viability of the cultures remained high as observed in Fig. 4(a);
this would suggest that the production of albumin had satu-
rated for all three samples rather than cell death causing
a reduction.
The albumin concentration observed in the 2D culture aer
24 hours was higher than the patterned and control samples,
probably due to a higher cell concentration linked to rapid initial
proliferation, but patterned cells subsequently have a higher
level. These results support the fact that aggregation of hepato-
cytes is critical to maintaining hepatic cellular functions,49 as it
has been observed that randomly dispersed low density seeding
of cells in agar reduces functionality and viability compared with
high density. Tightly packed aggregates with an average diameter
of 100 mm have shown increased albumin production compared
with randomly dispersed cells.49Conclusions
Cell patterning techniques to engineer biomimetic cell geome-
tries and to preserve cell-to-cell interactions are an important
aspect of constructing articial organs, for example for toxicity
testing. In this work, a novel technique is developed using DEP to
pattern cells into the livers' lobule-like structure in agar gels with
a paper substrate to facilitate long term studies of both viability,
and functionality. The functionality of the liver-lobule structures
in agar were investigated by examining the production of
albumin, which was increased in the micro liver engineered
tissue. The design allows the patterned cells to be removed from
the electrode substrate, to be placed within custom culture
platforms, for example containing microuidic channels. Addi-
tionally, multiple layers of paper ring micro livers could be con-
structed to increase the volume and complexity of these tissue-
engineered organs into an organ additive manufacturing system.Conﬂicts of interest
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